343 related articles for article (PubMed ID: 15280432)
21. Ubiquitin-dependent degradation of TGF-beta-activated smad2.
Lo RS; Massagué J
Nat Cell Biol; 1999 Dec; 1(8):472-8. PubMed ID: 10587642
[TBL] [Abstract][Full Text] [Related]
22. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
[TBL] [Abstract][Full Text] [Related]
23. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
[TBL] [Abstract][Full Text] [Related]
24. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
[TBL] [Abstract][Full Text] [Related]
25. Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells.
Grau AM; Datta PK; Zi J; Halder SK; Beauchamp RD
Cell Signal; 2006 Jul; 18(7):1041-50. PubMed ID: 16288847
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
27. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
[TBL] [Abstract][Full Text] [Related]
28. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
[TBL] [Abstract][Full Text] [Related]
31. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
32. STAT1 from the cell membrane to the DNA.
Lillemeier BF; Köster M; Kerr IM
EMBO J; 2001 May; 20(10):2508-17. PubMed ID: 11350940
[TBL] [Abstract][Full Text] [Related]
33. Smad translocation and growth suppression in lens epithelial cells by endogenous TGFbeta2 during wound repair.
Saika S; Okada Y; Miyamoto T; Ohnishi Y; Ooshima A; McAvoy JW
Exp Eye Res; 2001 Jun; 72(6):679-86. PubMed ID: 11384156
[TBL] [Abstract][Full Text] [Related]
34. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
Warner DR; Greene RM; Pisano MM
FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
[TBL] [Abstract][Full Text] [Related]
35. The smad proteins and TGFbeta signalling: uncovering a pathway critical in cancer.
Rooke HM; Crosier KE
Pathology; 2001 Feb; 33(1):73-84. PubMed ID: 11280614
[TBL] [Abstract][Full Text] [Related]
36. Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-beta ligands.
Batut J; Howell M; Hill CS
Dev Cell; 2007 Feb; 12(2):261-74. PubMed ID: 17276343
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta signalling from cell membrane to nucleus through SMAD proteins.
Heldin CH; Miyazono K; ten Dijke P
Nature; 1997 Dec; 390(6659):465-71. PubMed ID: 9393997
[TBL] [Abstract][Full Text] [Related]
38. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
[TBL] [Abstract][Full Text] [Related]
39. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
40. Green fluorescent protein-tagging reduces the nucleocytoplasmic shuttling specifically of unphosphorylated STAT1.
Meyer T; Begitt A; Vinkemeier U
FEBS J; 2007 Feb; 274(3):815-26. PubMed ID: 17288561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]